# Argatroban Versus Lepirudin in Critically Ill Patients

> **NCT00798525** · PHASE4 · TERMINATED · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 70 (actual)

## Conditions studied

- Heparin Induced Thrombocytopenia (HIT)

## Interventions

- **DRUG:** Argatroban
- **DRUG:** Lepirudin

## Key facts

- **NCT ID:** NCT00798525
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012
- **Last updated:** 2012-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798525, "Argatroban Versus Lepirudin in Critically Ill Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00798525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*